Kezar Life Sciences, Inc.
KZR
$3.96
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 17.23% | 18.11% | 0.47% | 5.73% | 0.51% |
| Total Depreciation and Amortization | -3.19% | -3.09% | -0.38% | -0.38% | 0.38% |
| Total Amortization of Deferred Charges | -73.58% | 140.91% | 3.13% | -1.54% | 1.56% |
| Total Other Non-Cash Items | -12.29% | -12.88% | 22.51% | -39.63% | 68.92% |
| Change in Net Operating Assets | 61.40% | -569.31% | 24.63% | -43.28% | 127.40% |
| Cash from Operations | 25.57% | -2.17% | 3.82% | -2.72% | 25.51% |
| Capital Expenditure | 100.00% | 27.27% | 38.89% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -17.11% | -42.12% | -1.34% | 97.10% | -40.14% |
| Cash from Investing | -17.06% | -42.12% | -1.31% | 96.95% | -40.14% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.68% | -2,874.47% | -- | -100.00% | -- |
| Foreign Exchange rate Adjustments | 540.00% | 106.67% | -568.75% | 433.33% | 142.86% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 44.49% | -168.89% | 4.69% | 238.39% | -93.25% |